Ignite Creation Date:
2024-05-06 @ 6:23 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05641493
Status:
RECRUITING
Last Update Posted:
2023-04-10
First Post:
2022-11-15
Brief Title:
A Phase IbII Clinical Trial to Evaluate the Safety and Efficacy of HLX208HLX10 in NSCLC With BRAF V600E Mutation
Sponsor:
Shanghai Henlius Biotech
Organization:
Shanghai Henlius Biotech